Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 281-290 of 664 for Cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study Of Ziftomenib, An Oral Menin Inhibitor, In Combination With Imatinib In Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study Of ABBV-383 With Relapsed Refractory Waldenström Macroglobulinemia

    Rochester, MN

  3. An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation In PSMA Positive OMPC. (PSMA-DC)

    Rochester, MN

  4. A Study Of Safety, Tolerability, Pharmacokinetic And Pharmacodynamics (PK/PD) In Patients With Hematologic Malignancies

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Novel Vaccine (EO2463) As Monotherapy And In Combination, For Treatment Of Patients With Indolent Non-Hodgkin Lymphoma

    Rochester, MN

  6. A Study Of The Drugs Selumetinib Vs. Carboplatin And Vincristine In Patients With Low-Grade Glioma

    Rochester, MN

  7. Retifanlimab With Bevacizumab And Hypofractionated Radiotherapy For The Treatment Of Recurrent Glioblastoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Anti-VEGF Gene Therapy Trial For Vestibular Schwannoma

    Rochester, MN

  9. Study Of Tirabrutinib Vs Rituximab/Temozolomide For Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. GATE1: A Multicenter Phase II Study Of Pirtobrutinib, Rituximab And Venetoclax Combination Therapy For Patients With Previously Untreated Mantle Cell Lymphoma

    Rochester, MN

.

Mayo Clinic Footer